Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00331162
Status:
COMPLETED
Last Update Posted:
2018-09-06
First Post:
2006-05-26
Brief Title:
Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation
Sponsor:
Organization:
Wake Forest University Health Sciences